As communicated on January 21, 2020, CTS will implement the licensed Grifols Babesia test for samples received on April 20, at the Charlotte, Dallas, Phoenix, St. Louis and Tampa laboratories. Babesia is a selective pooled NAT test, required for all blood donations collected by May 2020, in 14 States and the District of Columbia. To help you understand the requirements, CTS will host a Babesia Implementation and Review webinar on March 3, 2020 at 11:00 am CST. If you are interested in attending, please contact your Customer Service Manager for invitation details.
As a service to our partners, CTS provides a copy of all licenses and accreditations on our website....
We are very excited to launch our new website! Please take a few moments to click around and explore...
The revised CTS algorithm associated with the Ortho platform is now available for review. Clie...
We have now added a new section called the "Assay History List" to the "At A Gla...
The CTS forms listed below have been revised with an implementation date of September 2, 2019. ...
In response to the FDA guidance document for Babesia, CTS will implement the licensed Grifols ...